Streetbeat News

Products Services

CMRA

Comera Life Sciences has expanded its intellectual property portfolio with the issuance of four new patents and two new notices of allowance. This strengthens the proprietary SQore platform.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 12:23 pm

IXHL

Incannex Healthcare Ltd's subsidiary, Clarion Clinics Group, has begun accepting registrations of interest for its psychedelic-assisted therapy (PAT) treatments. The first clinic, located in Melbourne, is nearing completion and treatments are expected to commence following final approval of Authorised Psychiatrists by the Therapeutic Goods Administration (TGA). The treatments are aimed at the estimated 390,000 Australians suffering from post-traumatic stress disorder (PTSD) and 280,000 suffering from treatment-resistant depression (TRD).

Portfolio Pulse from Happy Mohamed

August 08, 2023 | 12:22 pm

INAB

IN8bio, Inc. (NASDAQ:INAB), a clinical-stage biopharmaceutical company, has announced the grand opening of its advanced research and development (R&D) facility in Birmingham, AL. The new facility will expand the company's preclinical, clinical, and process development capabilities, advancing its pipeline of innovative gamma-delta T cell therapies. The company aims to leverage the rich cancer research heritage of the University of Alabama at Birmingham (UAB) and create a transformative impact on the local community and the field of biotechnology.

Portfolio Pulse from Happy Mohamed

August 08, 2023 | 12:21 pm

RXRX

Recursion (NASDAQ:RXRX) has successfully screened the Enamine REAL Space chemical library using its MatchMaker technology, recently acquired from Cyclica, to predict the protein target(s) for approximately 36 billion chemical compounds. The company generated this massive new data layer of predicted interactions in less than 90 days after closing the acquisition of Cyclica and in under 30 days since initiating the collaboration with NVIDIA. Recursion plans to leverage this new database of predictions to industrialize its chemistry operations across its pipeline and in service to its partners.

Portfolio Pulse from Happy Mohamed

August 08, 2023 | 12:21 pm

NVO

Novo Nordisk A/S (NYSE:NVO) released the results from the SELECT cardiovascular outcomes trial, which showed a 20% reduction in major adverse cardiovascular events (MACEs) for people treated with semaglutide 2.4 mg compared to placebo. The trial enrolled 17,604 adults aged 45 years or older with overweight or obesity and established cardiovascular disease with no prior history of diabetes. Novo Nordisk expects to file for regulatory approvals of a label indication expansion for semaglutide 2.4 mg (Wegovy) in the U.S. and the EU in 2023.

Portfolio Pulse from Vandana Singh

August 08, 2023 | 12:20 pm

COCP

Cocrystal Pharma, Inc. (NASDAQ:COCP) has selected its novel oral protease inhibitor CDI-988 as a potential oral therapy for norovirus. The Phase 1 study of CDI-988 is approved by Australia Human Research Ethics Committees. Norovirus represents a significant unmet medical need with no approved treatments or vaccines. CDI-988 was specifically designed as a broad-spectrum antiviral inhibitor and has shown potent antiviral activity against a panel of pandemic GII.4 norovirus proteases.

Portfolio Pulse from Happy Mohamed

August 08, 2023 | 12:19 pm

APLD

Applied Digital Corporation (NASDAQ:APLD) has announced a strategic partnership with ZEDEDA, an edge orchestration leader. The partnership will allow Applied Digital to use ZEDEDA's management and orchestration software solution for its new on-demand Transmutable AI cloud service. This service will enable customers to purchase and use GPU resources on-demand and at scale across all of Applied Digital's data centers. The service is expected to go live during the second half of 2023.

Portfolio Pulse from Happy Mohamed

August 08, 2023 | 12:18 pm

BRAG

FLTR

Bragg Gaming Group (BRAG) has signed a global content distribution agreement with PokerStars, a brand from Flutter Entertainment (FLTR). The agreement will allow Bragg to provide a range of its games for PokerStars' customers worldwide. The roll-out will begin in Europe, followed by New Jersey, Michigan, and Pennsylvania. The agreement includes popular games from Bragg Studios and exclusive content from its Powered by Bragg portfolio.

Portfolio Pulse from Happy Mohamed

August 08, 2023 | 12:18 pm

URGN

Urogen Pharma has announced that The Journal of Urology has published data from the Phase 3 Atlas trial for investigational agent UGN-102. The trial showed UGN-102 demonstrated superiority to TURBT with a 55% reduction of risk for recurrence, progression or death in patients with low-grade, intermediate-risk non-muscle invasive bladder cancer.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 12:16 pm

CHPT

ChargePoint (NYSE:CHPT), a leading provider of electric vehicle (EV) charging solutions, announced a significant investment in technology to deliver nearly 100% charging station reliability. The company will implement 24/7 proactive station monitoring, predictive analytics, and machine learning to detect station downtime and improve charger uptime. ChargePoint also plans to introduce a comprehensive training program to certify electrical contractors that install EV charging infrastructure. The company currently delivers approximately 96% uptime across its entire public network in North America and Europe.

Portfolio Pulse from Happy Mohamed

August 08, 2023 | 12:14 pm